Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

422 projects found matching your search criteria :

  1. Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

    Call: OPUS 1 , Panel: ST5

    Principal investigator: prof. Tadeusz Andrzej Holak

    Uniwersytet Jagielloński, Wydział Chemii

  2. Selective inhibition of NMDAR activity during epileptogenesis as a therapeutic approach to cure epilepsy

    Call: SONATA 10 , Panel: NZ7

    Principal investigator: dr Adam Gorlewicz

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  3. The influence of emotion on perceptual processing, response inhibition and error monitoring. An event-related potential ...

    Call: OPUS 10 , Panel: HS6

    Principal investigator: dr hab. Magdalena Senderecka

    Uniwersytet Jagielloński, Wydział Filozoficzny

  4. Design, synthesis and biological evaluation of the new steroid sulfatase (STS) inhibitors based on sulfamate analogs con...

    Call: PRELUDIUM 10 , Panel: NZ7

    Principal investigator: Mateusz Daśko

    Politechnika Gdańska, Wydział Chemiczny

  5. New hydrids of tetrahydroacridine derivatives as a acetylocholinesterase with multifunctional activity

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Paweł Bartosz Szymański

    Uniwersytet Medyczny w Łodzi, Wydział Farmaceutyczny

  6. In vivo and in vitro structure of influenza virus RNA. The structural determinants behind the inhibition of influenza vi...

    Call: OPUS 10 , Panel: NZ1

    Principal investigator: prof. Elżbieta Kierzek

    Instytut Chemii Bioorganicznej Polskiej Akademii Nauk

  7. The role of cognitive inhibition in the involuntary mental time travel.A comprehensive investigation of involuntary auto...

    Call: SONATA 10 , Panel: HS6

    Principal investigator: dr Krystian Barzykowski

    Uniwersytet Jagielloński, Wydział Filozoficzny

  8. Modification of cellular aging in vitro by inhibitors of non-enzymatic protein modifications

    Call: OPUS 9 , Panel: NZ3

    Principal investigator: prof. Grzegorz Bartosz

    Uniwersytet Rzeszowski, Kolegium Nauk Przyrodniczych

  9. Using X-ray crystallography for localization of the sites of binding of allosteric inhibitors and activators within the ...

    Call: PRELUDIUM 9 , Panel: NZ1

    Principal investigator: Julia Witkowska

    Uniwersytet Gdański, Wydział Chemii

  10. Impact of the engineered mono-dispersed Fe3O4@SiO2 nanoparticles on a fungal enzyme inhibition in vitro

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Ahmet Kertmen

    Politechnika Gdańska, Wydział Chemiczny

  11. Quantitative model for predicting CYP inhibition parameters for novel arylpiperazine derivatives.

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: dr Szymon Ulenberg

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  12. Investigation of the antitumor potential of stimulator of interferon genes (STING) - an adaptor protein in innate immune...

    Call: PRELUDIUM 9 , Panel: NZ6

    Principal investigator: Olga Sokołowska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  13. Synthesis of new glutamate receptors antagonists and extensive investigation of their effect on tumor cells in the prese...

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Maria Wanda Bretner

    Politechnika Warszawska, Wydział Chemiczny

  14. New MOF compounds as degradable nanocontainers of tyrosine kinases inhibitors in novel anti-cancer therapy

    Call: OPUS 9 , Panel: ST5

    Principal investigator: prof. Artur Piotr Terzyk

    Uniwersytet Mikołaja Kopernika w Toruniu, Wydział Chemii

  15. The use of microRNA inhibitors for restoration of the expression of tumor suppressor, gene SLC5A8, and establishing of t...

    Call: PRELUDIUM 9 , Panel: NZ2

    Principal investigator: Wojciech Gierlikowski

    Warszawski Uniwersytet Medyczny, I Wydział Lekarski

  16. Targeting histone deacetylases as an approach to treat neonatal asphyxia.

    Call: PRELUDIUM 9 , Panel: NZ7

    Principal investigator: Joanna Jaworska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  17. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Call: PRELUDIUM 9 , Panel: NZ3

    Principal investigator: Alicja Patrycja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  18. Insight into biochemistry, structure, evolution and biology of bacterial serpins on example of miropin from human pathog...

    Call: OPUS 9 , Panel: NZ1

    Principal investigator: dr Mirosław Książek

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  19. New approach in bisubstrate analogs inhibitors designing.

    Call: PRELUDIUM 9 , Panel: NZ1

    Principal investigator: dr Maria Izabella Winiewska-Szajewska

    Instytut Biochemii i Biofizyki Polskiej Akademii Nauk

  20. Protein and gene expression analysis in the course of renal cancer stem-like cells' primary resistance to sorafenib in h...

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Zofia Felicja Bielecka

    Wojskowy Instytut Medyczny

  21. Chemo-genetic investigation of the role of inhibitory interneurons containing somatostatin in cerebral cortex plasticity

    Call: OPUS 9 , Panel: NZ4

    Principal investigator: prof. Małgorzata Maria Kossut

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  22. Covalent inhibiors of bacterial ureases - design, activity and mode of binding

    Call: PRELUDIUM 9 , Panel: NZ1

    Principal investigator: dr Katarzyna Magdalena Macegoniuk

    Politechnika Wrocławska, Wydział Chemiczny